NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $502,328 | -2.1% | 4,975 | -1.2% | 0.40% | -20.1% |
| Q3 2023 | $512,962 | -3.4% | 5,036 | -4.3% | 0.50% | -5.3% |
| Q2 2023 | $531,156 | +5.1% | 5,264 | -4.2% | 0.53% | -9.4% |
| Q1 2023 | $505,441 | -5.9% | 5,494 | -7.2% | 0.58% | -10.1% |
| Q4 2022 | $537,311 | +10.6% | 5,923 | -7.4% | 0.65% | +5.3% |
| Q3 2022 | $486,000 | -21.0% | 6,399 | -12.0% | 0.62% | -11.6% |
| Q2 2022 | $615,000 | -8.3% | 7,273 | -4.9% | 0.70% | +8.7% |
| Q1 2022 | $671,000 | +11.6% | 7,650 | +11.3% | 0.64% | +17.1% |
| Q4 2021 | $601,000 | +14.9% | 6,874 | +7.6% | 0.55% | +2.0% |
| Q3 2021 | $523,000 | – | 6,390 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |